Warning: The NCBI web site requires JavaScript to function. more...
Metabolic management of glioblastoma multiforme using standard therapy together with a restricted ketogenic diet: Case Report.
Zuccoli G, Marcello N, Pisanello A, Servadei F, Vaccaro S, Mukherjee P, Seyfried TN.
Nutr Metab (Lond). 2010 Apr 22;7:33.
Related citations
Final Report on Carcinogens Background Document for Formaldehyde.
National Toxicology Program.
Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.
The calorically restricted ketogenic diet, an effective alternative therapy for malignant brain cancer.
Zhou W, Mukherjee P, Kiebish MA, Markis WT, Mantis JG, Seyfried TN.
Nutr Metab (Lond). 2007 Feb 21;4:5.
Final Report on Carcinogens Background Document for Styrene.
Rep Carcinog Backgr Doc. 2008 Sep;(8-5978):i-398.
Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation.
Tralins KS, Douglas JG, Stelzer KJ, Mankoff DA, Silbergeld DL, Rostomily RC, Hummel S, Scharnhorst J, Krohn KA, Spence AM.
J Nucl Med. 2002 Dec;43(12):1667-73. Erratum in: J Nucl Med. 2003 Oct;44(10):1603. Rostomilly Robert [corrected to Rostomily Robert C].
Canadian recommendations for the treatment of glioblastoma multiforme.
Mason WP, Maestro RD, Eisenstat D, Forsyth P, Fulton D, Laperrière N, Macdonald D, Perry J, Thiessen B; Canadian GBM Recommendations Committee.
Curr Oncol. 2007 Jun;14(3):110-7.
Drug/diet synergy for managing malignant astrocytoma in mice: 2-deoxy-D-glucose and the restricted ketogenic diet.
Marsh J, Mukherjee P, Seyfried TN.
Nutr Metab (Lond). 2008 Nov 25;5:33.
Improvement in motor and exploratory behavior in Rett syndrome mice with restricted ketogenic and standard diets.
Mantis JG, Fritz CL, Marsh J, Heinrichs SC, Seyfried TN.
Epilepsy Behav. 2009 Jun;15(2):133-41. Epub 2009 Feb 26.
Usefulness of 3'-[F-18]fluoro-3'-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy.
Pio BS, Park CK, Pietras R, Hsueh WA, Satyamurthy N, Pegram MD, Czernin J, Phelps ME, Silverman DH.
Mol Imaging Biol. 2006 Jan-Feb;8(1):36-42.
Positron emission tomography with fluorodeoxyglucose to evaluate tumor response and control after radiation therapy.
Chaiken L, Rege S, Hoh C, Choi Y, Jabour B, Juillard G, Hawkins R, Parker R.
Int J Radiat Oncol Biol Phys. 1993 Sep 30;27(2):455-64.
Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
Grosu AL, Weber WA, Franz M, Stärk S, Piert M, Thamm R, Gumprecht H, Schwaiger M, Molls M, Nieder C.
Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):511-9.
Secondary gliosarcoma after diagnosis of glioblastoma: clinical experience with 30 consecutive patients.
Han SJ, Yang I, Otero JJ, Ahn BJ, Tihan T, McDermott MW, Berger MS, Chang SM, Parsa AT.
J Neurosurg. 2010 May;112(5):990-6.
Effects of a ketogenic diet on tumor metabolism and nutritional status in pediatric oncology patients: two case reports.
Nebeling LC, Miraldi F, Shurin SB, Lerner E.
J Am Coll Nutr. 1995 Apr;14(2):202-8.
A ketogenic diet increases brain insulin-like growth factor receptor and glucose transporter gene expression.
Cheng CM, Kelley B, Wang J, Strauss D, Eagles DA, Bondy CA.
Endocrinology. 2003 Jun;144(6):2676-82.
Prolonged survival of a patient with cervical intramedullary glioblastoma multiforme treated with total resection, radiation therapy, and temozolomide.
Tseng HM, Kuo LT, Lien HC, Liu KL, Liu MT, Huang CY.
Anticancer Drugs. 2010 Nov;21(10):963-7.
Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme.
Turner CD, Chi S, Marcus KJ, MacDonald T, Packer RJ, Poussaint TY, Vajapeyam S, Ullrich N, Goumnerova LC, Scott RM, Briody C, Chordas C, Zimmerman MA, Kieran MW.
J Neurooncol. 2007 Mar;82(1):95-101. Epub 2006 Sep 22.
Evaluation of early response to SU101 target-based therapy in patients with recurrent supratentorial malignant gliomas using FDG PET and Gd-DTPA MRI.
Vlassenko AG, Thiessen B, Beattie BJ, Malkin MG, Blasberg RG.
J Neurooncol. 2000;46(3):249-59.
Is the restricted ketogenic diet a viable alternative to the standard of care for managing malignant brain cancer?
Seyfried TN, Marsh J, Shelton LM, Huysentruyt LC, Mukherjee P.
Epilepsy Res. 2011 Aug 30. [Epub ahead of print]
MGMT promoter methylation status can predict the incidence and outcome of pseudoprogression after concomitant radiochemotherapy in newly diagnosed glioblastoma patients.
Brandes AA, Franceschi E, Tosoni A, Blatt V, Pession A, Tallini G, Bertorelle R, Bartolini S, Calbucci F, Andreoli A, Frezza G, Leonardi M, Spagnolli F, Ermani M.
J Clin Oncol. 2008 May 1;26(13):2192-7.
Prognostic implication of clinical and pathologic features in patients with glioblastoma multiforme treated with concomitant radiation plus temozolomide.
Donato V, Papaleo A, Castrichino A, Banelli E, Giangaspero F, Salvati M, Delfini R.
Tumori. 2007 May-Jun;93(3):248-56.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on